Selected research
Industry Growth & Trends
Global Cystic Fibrosis Drugs Industry Growth and Trends Forecast to 2032
Market perspective
The global Cystic Fibrosis Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Cystic Fibrosis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Cystic Fibrosis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cystic Fibrosis Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cystic Fibrosis Drugs include Abbott, Johnson & Johnson, Novartis, Vertex Pharmaceuticals, Venus Remedies, United Medical, PTC Therapeutics, Proteostasis Therapeutics and Pharmaxis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Cystic Fibrosis Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Cystic Fibrosis Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cystic Fibrosis Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cystic Fibrosis Drugs.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Cystic Fibrosis Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Cystic Fibrosis Drugs Market by Company
Abbott
Johnson & Johnson
Novartis
Vertex Pharmaceuticals
Venus Remedies
United Medical
PTC Therapeutics
Proteostasis Therapeutics
Pharmaxis
PharmaSwiss
Novo Nordisk
Neovii Biotech
Merck Sharp & Dohme
Insmed
Gilead Sciences
Genzyme
F. Hoffmann-La Roche
Corbus Pharmaceuticals
Chiesi Farmaceutici
Boehringer Ingelheim
Arcturus Therapeutics
Anthera Pharmaceuticals
Actavis
Cystic Fibrosis Drugs Segment by Type
Oral Cystic Fibrosis Drugs
Injection Cystic Fibrosis Drugs
Cystic Fibrosis Drugs Segment by Application
Hospitals
Clinics
Other
Cystic Fibrosis Drugs Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cystic Fibrosis Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cystic Fibrosis Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cystic Fibrosis Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cystic Fibrosis Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Cystic Fibrosis Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
List of Tables
Table 1. Major Company of Oral Cystic Fibrosis Drugs
Table 2. Major Company of Injection Cystic Fibrosis Drugs
Table 3. Global Cystic Fibrosis Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Global Cystic Fibrosis Drugs Sales by Type (2021-2026) & (K Units)
Table 5. Global Cystic Fibrosis Drugs Sales Market Share in Volume by Type (2021-2026)
Table 6. Global Cystic Fibrosis Drugs Sales by Type (2021-2026) & (US$ Million)
Table 7. Global Cystic Fibrosis Drugs Sales Market Share in Value by Type (2021-2026)
Table 8. Global Cystic Fibrosis Drugs Price by Type (2021-2026) & (US$/Unit)
Table 9. Global Cystic Fibrosis Drugs Sales by Type (2027-2032) & (K Units)
Table 10. Global Cystic Fibrosis Drugs Sales Market Share in Volume by Type (2027-2032)
Table 11. Global Cystic Fibrosis Drugs Sales by Type (2027-2032) & (US$ Million)
Table 12. Global Cystic Fibrosis Drugs Sales Market Share in Value by Type (2027-2032)
Table 13. Global Cystic Fibrosis Drugs Price by Type (2027-2032) & (US$/Unit)
Table 14. North America Cystic Fibrosis Drugs Sales by Type (2021-2026) & (K Units)
Table 15. North America Cystic Fibrosis Drugs Sales by Type (2021-2026) & (US$ Million)
Table 16. Europe Cystic Fibrosis Drugs Sales by Type (2021-2026) & (K Units)
Table 17. Europe Cystic Fibrosis Drugs Sales by Type (2021-2026) & (US$ Million)
Table 18. Asia-Pacific Cystic Fibrosis Drugs Sales by Type (2021-2026) & (K Units)
Table 19. Asia-Pacific Cystic Fibrosis Drugs Sales by Type (2021-2026) & (US$ Million)
Table 20. Latin America Cystic Fibrosis Drugs Sales by Type (2021-2026) & (K Units)
Table 21. Latin America Cystic Fibrosis Drugs Sales by Type (2021-2026) & (US$ Million)
Table 22. Middle East and Africa Cystic Fibrosis Drugs Sales by Type (2021-2026) & (K Units)
Table 23. Middle East and Africa Cystic Fibrosis Drugs Sales by Type (2021-2026) & (US$ Million)
Table 24. Cystic Fibrosis Drugs Industry Trends
Table 25. Cystic Fibrosis Drugs Industry Drivers
Table 26. Cystic Fibrosis Drugs Industry Opportunities and Challenges
Table 27. Cystic Fibrosis Drugs Industry Restraints
Table 28. Global Cystic Fibrosis Drugs Sales Revenue by Company (US$ Million) & (2021-2026)
Table 29. Global Cystic Fibrosis Drugs Revenue Market Share by Company (2021-2026)
Table 30. Global Cystic Fibrosis Drugs Sales by Company (2021-2026) & (K Units)
Table 31. Global Cystic Fibrosis Drugs Sales Share by Company (2021-2026)
Table 32. Global Cystic Fibrosis Drugs Market Price by Company (2021-2026) & (US$/Unit)
Table 33. Global Cystic Fibrosis Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
Table 34. Global Cystic Fibrosis Drugs Major Company Production Sites and Headquarters
Table 35. Global Cystic Fibrosis Drugs Company, Product Type & Application
Table 36. Global Cystic Fibrosis Drugs Company Establishment Date
Table 37. Global Company Market Concentration Ratio (CR5 and HHI)
Table 38. Global Cystic Fibrosis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 39. Global Cystic Fibrosis Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032
Table 40. Global Cystic Fibrosis Drugs Sales by Region (2021-2026) & (K Units)
Table 41. Global Cystic Fibrosis Drugs Sales Market Share in Volume by Region (2021-2026)
Table 42. Global Cystic Fibrosis Drugs Sales by Region (2021-2026) & (US$ Million)
Table 43. Global Cystic Fibrosis Drugs Sales Market Share in Value by Region (2021-2026)
Table 44. Global Cystic Fibrosis Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 45. Global Cystic Fibrosis Drugs Sales by Region (2027-2032) & (K Units)
Table 46. Global Cystic Fibrosis Drugs Sales Market Share in Volume by Region (2027-2032)
Table 47. Global Cystic Fibrosis Drugs Sales by Region (2027-2032) & (US$ Million)
Table 48. Global Cystic Fibrosis Drugs Sales Market Share in Value by Region (2027-2032)
Table 49. Global Cystic Fibrosis Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032)
Table 50. Global Cystic Fibrosis Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 51. Global Cystic Fibrosis Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Global Cystic Fibrosis Drugs Sales Market Share in Volume by Application (2021-2026)
Table 53. Global Cystic Fibrosis Drugs Sales by Application (2021-2026) & (US$ Million)
Table 54. Global Cystic Fibrosis Drugs Sales Market Share in Value by Application (2021-2026)
Table 55. Global Cystic Fibrosis Drugs Price by Application (2021-2026) & (US$/Unit)
Table 56. Global Cystic Fibrosis Drugs Sales by Application (2027-2032) & (K Units)
Table 57. Global Cystic Fibrosis Drugs Sales Market Share in Volume by Application (2027-2032)
Table 58. Global Cystic Fibrosis Drugs Sales by Application (2027-2032) & (US$ Million)
Table 59. Global Cystic Fibrosis Drugs Sales Market Share in Value by Application (2027-2032)
Table 60. Global Cystic Fibrosis Drugs Price by Application (2027-2032) & (US$/Unit)
Table 61. North America Cystic Fibrosis Drugs Sales by Application (2021-2026) & (K Units)
Table 62. North America Cystic Fibrosis Drugs Sales by Application (2021-2026) & (US$ Million)
Table 63. Europe Cystic Fibrosis Drugs Sales by Application (2021-2026) & (K Units)
Table 64. Europe Cystic Fibrosis Drugs Sales by Application (2021-2026) & (US$ Million)
Table 65. Asia-Pacific Cystic Fibrosis Drugs Sales by Application (2021-2026) & (K Units)
Table 66. Asia-Pacific Cystic Fibrosis Drugs Sales by Application (2021-2026) & (US$ Million)
Table 67. Latin America Cystic Fibrosis Drugs Sales by Application (2021-2026) & (K Units)
Table 68. Latin America Cystic Fibrosis Drugs Sales by Application (2021-2026) & (US$ Million)
Table 69. Middle East and Africa Cystic Fibrosis Drugs Sales by Application (2021-2026) & (K Units)
Table 70. Middle East and Africa Cystic Fibrosis Drugs Sales by Application (2021-2026) & (US$ Million)
Table 71. Abbott Company Information
Table 72. Abbott Business Overview
Table 73. Abbott Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 74. Abbott Cystic Fibrosis Drugs Product Portfolio
Table 75. Abbott Recent Development
Table 76. Johnson & Johnson Company Information
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 79. Johnson & Johnson Cystic Fibrosis Drugs Product Portfolio
Table 80. Johnson & Johnson Recent Development
Table 81. Novartis Company Information
Table 82. Novartis Business Overview
Table 83. Novartis Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 84. Novartis Cystic Fibrosis Drugs Product Portfolio
Table 85. Novartis Recent Development
Table 86. Vertex Pharmaceuticals Company Information
Table 87. Vertex Pharmaceuticals Business Overview
Table 88. Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
Table 90. Vertex Pharmaceuticals Recent Development
Table 91. Venus Remedies Company Information
Table 92. Venus Remedies Business Overview
Table 93. Venus Remedies Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. Venus Remedies Cystic Fibrosis Drugs Product Portfolio
Table 95. Venus Remedies Recent Development
Table 96. United Medical Company Information
Table 97. United Medical Business Overview
Table 98. United Medical Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. United Medical Cystic Fibrosis Drugs Product Portfolio
Table 100. United Medical Recent Development
Table 101. PTC Therapeutics Company Information
Table 102. PTC Therapeutics Business Overview
Table 103. PTC Therapeutics Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. PTC Therapeutics Cystic Fibrosis Drugs Product Portfolio
Table 105. PTC Therapeutics Recent Development
Table 106. Proteostasis Therapeutics Company Information
Table 107. Proteostasis Therapeutics Business Overview
Table 108. Proteostasis Therapeutics Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Proteostasis Therapeutics Cystic Fibrosis Drugs Product Portfolio
Table 110. Proteostasis Therapeutics Recent Development
Table 111. Pharmaxis Company Information
Table 112. Pharmaxis Business Overview
Table 113. Pharmaxis Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Pharmaxis Cystic Fibrosis Drugs Product Portfolio
Table 115. Pharmaxis Recent Development
Table 116. PharmaSwiss Company Information
Table 117. PharmaSwiss Business Overview
Table 118. PharmaSwiss Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. PharmaSwiss Cystic Fibrosis Drugs Product Portfolio
Table 120. PharmaSwiss Recent Development
Table 121. Novo Nordisk Company Information
Table 122. Novo Nordisk Business Overview
Table 123. Novo Nordisk Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Novo Nordisk Cystic Fibrosis Drugs Product Portfolio
Table 125. Novo Nordisk Recent Development
Table 126. Neovii Biotech Company Information
Table 127. Neovii Biotech Business Overview
Table 128. Neovii Biotech Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. Neovii Biotech Cystic Fibrosis Drugs Product Portfolio
Table 130. Neovii Biotech Recent Development
Table 131. Merck Sharp & Dohme Company Information
Table 132. Merck Sharp & Dohme Business Overview
Table 133. Merck Sharp & Dohme Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Merck Sharp & Dohme Cystic Fibrosis Drugs Product Portfolio
Table 135. Merck Sharp & Dohme Recent Development
Table 136. Insmed Company Information
Table 137. Insmed Business Overview
Table 138. Insmed Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 139. Insmed Cystic Fibrosis Drugs Product Portfolio
Table 140. Insmed Recent Development
Table 141. Gilead Sciences Company Information
Table 142. Gilead Sciences Business Overview
Table 143. Gilead Sciences Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 144. Gilead Sciences Cystic Fibrosis Drugs Product Portfolio
Table 145. Gilead Sciences Recent Development
Table 146. Genzyme Company Information
Table 147. Genzyme Business Overview
Table 148. Genzyme Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 149. Genzyme Cystic Fibrosis Drugs Product Portfolio
Table 150. Genzyme Recent Development
Table 151. F. Hoffmann-La Roche Company Information
Table 152. F. Hoffmann-La Roche Business Overview
Table 153. F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 154. F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Portfolio
Table 155. F. Hoffmann-La Roche Recent Development
Table 156. Corbus Pharmaceuticals Company Information
Table 157. Corbus Pharmaceuticals Business Overview
Table 158. Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 159. Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
Table 160. Corbus Pharmaceuticals Recent Development
Table 161. Chiesi Farmaceutici Company Information
Table 162. Chiesi Farmaceutici Business Overview
Table 163. Chiesi Farmaceutici Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 164. Chiesi Farmaceutici Cystic Fibrosis Drugs Product Portfolio
Table 165. Chiesi Farmaceutici Recent Development
Table 166. Boehringer Ingelheim Company Information
Table 167. Boehringer Ingelheim Business Overview
Table 168. Boehringer Ingelheim Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 169. Boehringer Ingelheim Cystic Fibrosis Drugs Product Portfolio
Table 170. Boehringer Ingelheim Recent Development
Table 171. Arcturus Therapeutics Company Information
Table 172. Arcturus Therapeutics Business Overview
Table 173. Arcturus Therapeutics Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 174. Arcturus Therapeutics Cystic Fibrosis Drugs Product Portfolio
Table 175. Arcturus Therapeutics Recent Development
Table 176. Anthera Pharmaceuticals Company Information
Table 177. Anthera Pharmaceuticals Business Overview
Table 178. Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 179. Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
Table 180. Anthera Pharmaceuticals Recent Development
Table 181. Actavis Company Information
Table 182. Actavis Business Overview
Table 183. Actavis Cystic Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 184. Actavis Cystic Fibrosis Drugs Product Portfolio
Table 185. Actavis Recent Development
Table 186. North America Cystic Fibrosis Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032
Table 187. North America Cystic Fibrosis Drugs Sales by Country (2021-2026) & (K Units)
Table 188. North America Cystic Fibrosis Drugs Sales Market Share by Country (2021-2026)
Table 189. North America Cystic Fibrosis Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 190. North America Cystic Fibrosis Drugs Sales Market Share Forecast by Country (2027-2032)
Table 191. North America Cystic Fibrosis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 192. North America Cystic Fibrosis Drugs Market Size by Country (2021-2026) & (US$ Million)
Table 193. North America Cystic Fibrosis Drugs Market Share by Country (2021-2026)
Table 194. North America Cystic Fibrosis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 195. North America Cystic Fibrosis Drugs Market Share Forecast by Country (2027-2032)
Table 196. Europe Cystic Fibrosis Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032
Table 197. Europe Cystic Fibrosis Drugs Sales by Country (2021-2026) & (K Units)
Table 198. Europe Cystic Fibrosis Drugs Sales Market Share by Country (2021-2026)
Table 199. Europe Cystic Fibrosis Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 200. Europe Cystic Fibrosis Drugs Sales Market Share Forecast by Country (2027-2032)
Table 201. Europe Cystic Fibrosis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 202. Europe Cystic Fibrosis Drugs Market Size by Country (2021-2026) & (US$ Million)
Table 203. Europe Cystic Fibrosis Drugs Market Share by Country (2021-2026)
Table 204. Europe Cystic Fibrosis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 205. Europe Cystic Fibrosis Drugs Market Share Forecast by Country (2027-2032)
Table 206. Asia-Pacific Cystic Fibrosis Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032
Table 207. Asia-Pacific Cystic Fibrosis Drugs Sales by Country (2021-2026) & (K Units)
Table 208. Asia-Pacific Cystic Fibrosis Drugs Sales Market Share by Country (2021-2026)
Table 209. Asia-Pacific Cystic Fibrosis Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 210. Asia-Pacific Cystic Fibrosis Drugs Sales Market Share Forecast by Country (2027-2032)
Table 211. Asia-Pacific Cystic Fibrosis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 212. Asia-Pacific Cystic Fibrosis Drugs Market Size by Country (2021-2026) & (US$ Million)
Table 213. Asia-Pacific Cystic Fibrosis Drugs Market Share by Country (2021-2026)
Table 214. Asia-Pacific Cystic Fibrosis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 215. Asia-Pacific Cystic Fibrosis Drugs Market Share Forecast by Country (2027-2032)
Table 216. Latin America Cystic Fibrosis Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032
Table 217. Latin America Cystic Fibrosis Drugs Sales by Country (2021-2026) & (K Units)
Table 218. Latin America Cystic Fibrosis Drugs Sales Market Share by Country (2021-2026)
Table 219. Latin America Cystic Fibrosis Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 220. Latin America Cystic Fibrosis Drugs Sales Market Share Forecast by Country (2027-2032)
Table 221. Latin America Cystic Fibrosis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 222. Latin America Cystic Fibrosis Drugs Market Size by Country (2021-2026) & (US$ Million)
Table 223. Latin America Cystic Fibrosis Drugs Market Share by Country (2021-2026)
Table 224. Latin America Cystic Fibrosis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 225. Latin America Cystic Fibrosis Drugs Market Share Forecast by Country (2027-2032)
Table 226. Middle East and Africa Cystic Fibrosis Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032
Table 227. Middle East and Africa Cystic Fibrosis Drugs Sales by Country (2021-2026) & (K Units)
Table 228. Middle East and Africa Cystic Fibrosis Drugs Sales Market Share by Country (2021-2026)
Table 229. Middle East and Africa Cystic Fibrosis Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 230. Middle East and Africa Cystic Fibrosis Drugs Sales Market Share Forecast by Country (2027-2032)
Table 231. Middle East and Africa Cystic Fibrosis Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032
Table 232. Middle East and Africa Cystic Fibrosis Drugs Market Size by Country (2021-2026) & (US$ Million)
Table 233. Middle East and Africa Cystic Fibrosis Drugs Market Share by Country (2021-2026)
Table 234. Middle East and Africa Cystic Fibrosis Drugs Market Size Forecast by Country (2027-2032) & (US$ Million)
Table 235. Middle East and Africa Cystic Fibrosis Drugs Market Share Forecast by Country (2027-2032)
Table 236. Key Raw Materials
Table 237. Raw Materials Key Suppliers
Table 238. Cystic Fibrosis Drugs Distributors List
Table 239. Cystic Fibrosis Drugs Customers List
Table 240. Research Programs/Design for This Report
Table 241. Authors List of This Report
Table 242. Secondary Sources
Table 243. Primary Sources
List of Figures
Figure 1. Cystic Fibrosis Drugs Image
Figure 2. Global Cystic Fibrosis Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Cystic Fibrosis Drugs Market Size (2021-2032) & (US$ Million)
Figure 4. Global Cystic Fibrosis Drugs Sales (2021-2032) & (K Units)
Figure 5. Oral Cystic Fibrosis Drugs Image
Figure 6. Global Oral Cystic Fibrosis Drugs Sales YoY Growth (2021-2032) & (K Units)
Figure 7. Injection Cystic Fibrosis Drugs Image
Figure 8. Global Injection Cystic Fibrosis Drugs Sales YoY Growth (2021-2032) & (K Units)
Figure 9. Global Cystic Fibrosis Drugs Market Size Overview by Type (2021-2032) & (US$ Million)
Figure 10. Global Cystic Fibrosis Drugs Market Share by Type 2025 VS 2032
Figure 11. North America Cystic Fibrosis Drugs Sales Market Share in Volume by Type in 2025
Figure 12. North America Cystic Fibrosis Drugs Sales Market Share in Value by Type in 2025
Figure 13. Europe Cystic Fibrosis Drugs Sales Market Share in Volume by Type in 2025
Figure 14. Europe Cystic Fibrosis Drugs Sales Market Share in Value by Type in 2025
Figure 15. Asia-Pacific Cystic Fibrosis Drugs Sales Market Share in Volume by Type in 2025
Figure 16. Asia-Pacific Cystic Fibrosis Drugs Sales Market Share in Value by Type in 2025
Figure 17. Latin America Cystic Fibrosis Drugs Sales Market Share in Volume by Type in 2025
Figure 18. Latin America Cystic Fibrosis Drugs Sales Market Share in Value by Type in 2025
Figure 19. Middle East and Africa Cystic Fibrosis Drugs Sales Market Share in Volume by Type in 2025
Figure 20. Middle East and Africa Cystic Fibrosis Drugs Sales Market Share in Value by Type in 2025
Figure 21. Global Top 5 and 10 Cystic Fibrosis Drugs Players Market Share by Revenue in 2025
Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 23. Hospitals Image
Figure 24. Global Hospitals Sales YoY Growth (2021-2032) & (K Units)
Figure 25. Clinics Image
Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (K Units)
Figure 27. Other Image
Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units)
Figure 29. Global Cystic Fibrosis Drugs Market Size Overview by Application (2021-2032) & (US$ Million)
Figure 30. Global Cystic Fibrosis Drugs Market Share by Application 2025 VS 2032
Figure 31. North America Cystic Fibrosis Drugs Sales Market Share in Volume by Application in 2025
Figure 32. North America Cystic Fibrosis Drugs Sales Market Share in Value by Application in 2025
Figure 33. Europe Cystic Fibrosis Drugs Sales Market Share in Volume by Application in 2025
Figure 34. Europe Cystic Fibrosis Drugs Sales Market Share in Value by Application in 2025
Figure 35. Asia-Pacific Cystic Fibrosis Drugs Sales Market Share in Volume by Application in 2025
Figure 36. Asia-Pacific Cystic Fibrosis Drugs Sales Market Share in Value by Application in 2025
Figure 37. Latin America Cystic Fibrosis Drugs Sales Market Share in Volume by Application in 2025
Figure 38. Latin America Cystic Fibrosis Drugs Sales Market Share in Value by Application in 2025
Figure 39. Middle East and Africa Cystic Fibrosis Drugs Sales Market Share in Volume by Application in 2025
Figure 40. Middle East and Africa Cystic Fibrosis Drugs Sales Market Share in Value by Application in 2025
Figure 41. North America Cystic Fibrosis Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units)
Figure 42. North America Cystic Fibrosis Drugs Sales Share by Country: 2021 VS 2025 VS 2032
Figure 43. North America Cystic Fibrosis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 44. North America Cystic Fibrosis Drugs Market Share by Country: 2021 VS 2025 VS 2032
Figure 45. Europe Cystic Fibrosis Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units)
Figure 46. Europe Cystic Fibrosis Drugs Sales Share by Country: 2021 VS 2025 VS 2032
Figure 47. Europe Cystic Fibrosis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 48. Europe Cystic Fibrosis Drugs Market Share by Country: 2021 VS 2025 VS 2032
Figure 49. Asia-Pacific Cystic Fibrosis Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units)
Figure 50. Asia-Pacific Cystic Fibrosis Drugs Sales Share by Country: 2021 VS 2025 VS 2032
Figure 51. Asia-Pacific Cystic Fibrosis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 52. Asia-Pacific Cystic Fibrosis Drugs Market Share by Country: 2021 VS 2025 VS 2032
Figure 53. Latin America Cystic Fibrosis Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units)
Figure 54. Latin America Cystic Fibrosis Drugs Sales Share by Country: 2021 VS 2025 VS 2032
Figure 55. Latin America Cystic Fibrosis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 56. Latin America Cystic Fibrosis Drugs Market Share by Country: 2021 VS 2025 VS 2032
Figure 57. Middle East and Africa Cystic Fibrosis Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units)
Figure 58. Middle East and Africa Cystic Fibrosis Drugs Sales Share by Country: 2021 VS 2025 VS 2032
Figure 59. Middle East and Africa Cystic Fibrosis Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million)
Figure 60. Middle East and Africa Cystic Fibrosis Drugs Market Share by Country: 2021 VS 2025 VS 2032
Figure 61. Cystic Fibrosis Drugs Value Chain
Figure 62. Key Raw Materials Price
Figure 63. Manufacturing Cost Structure
Figure 64. Cystic Fibrosis Drugs Production Mode & Process
Figure 65. Direct Comparison with Distribution Share
Figure 66. Distributors Profiles
Figure 67. Years Considered
Figure 68. Research Process
Figure 69. Key Executives Interviewed
Scope & coverage.
Types
- Oral Cystic Fibrosis Drugs
- Injection Cystic Fibrosis Drugs
Applications
- Hospitals
- Clinics
- Other
Companies covered
- Abbott
- Johnson & Johnson
- Novartis
- Vertex Pharmaceuticals
- Venus Remedies
- United Medical
- PTC Therapeutics
- Proteostasis Therapeutics
- Pharmaxis
- PharmaSwiss
- Novo Nordisk
- Neovii Biotech
- Merck Sharp & Dohme
- Insmed
- Gilead Sciences
- Genzyme
- F. Hoffmann-La Roche
- Corbus Pharmaceuticals
- Chiesi Farmaceutici
- Boehringer Ingelheim
- Arcturus Therapeutics
- Anthera Pharmaceuticals
- Actavis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Cystic Fibrosis Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Cystic Fibrosis Drugs Sales Estimates and Forecasts (2021-2032)
- 1.3 Cystic Fibrosis Drugs Market by Type
- 1.3.1 Oral Cystic Fibrosis Drugs
- 1.3.2 Injection Cystic Fibrosis Drugs
- 1.4 Global Cystic Fibrosis Drugs Market Size by Type
- 1.4.1 Global Cystic Fibrosis Drugs Market Size Overview by Type (2021-2032)
- 1.4.2 Global Cystic Fibrosis Drugs Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Cystic Fibrosis Drugs Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Cystic Fibrosis Drugs Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Cystic Fibrosis Drugs Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Cystic Fibrosis Drugs Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Cystic Fibrosis Drugs Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Cystic Fibrosis Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Cystic Fibrosis Drugs Industry Trends
- 2.2 Cystic Fibrosis Drugs Industry Drivers
- 2.3 Cystic Fibrosis Drugs Industry Opportunities and Challenges
- 2.4 Cystic Fibrosis Drugs Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Cystic Fibrosis Drugs Revenue (2021-2026)
- 3.2 Global Top Players by Cystic Fibrosis Drugs Sales (2021-2026)
- 3.3 Global Top Players by Cystic Fibrosis Drugs Price (2021-2026)
- 3.4 Global Cystic Fibrosis Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cystic Fibrosis Drugs Major Company Production Sites & Headquarters
- 3.6 Global Cystic Fibrosis Drugs Company, Product Type & Application
- 3.7 Global Cystic Fibrosis Drugs Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cystic Fibrosis Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cystic Fibrosis Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Cystic Fibrosis Drugs Tier 1, Tier 2, and Tier 3
4 Cystic Fibrosis Drugs Regional Status and Outlook
- 4.1 Global Cystic Fibrosis Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Cystic Fibrosis Drugs Historic Market Size by Region
- 4.2.1 Global Cystic Fibrosis Drugs Sales in Volume by Region (2021-2026)
- 4.2.2 Global Cystic Fibrosis Drugs Sales in Value by Region (2021-2026)
- 4.2.3 Global Cystic Fibrosis Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Cystic Fibrosis Drugs Forecasted Market Size by Region
- 4.3.1 Global Cystic Fibrosis Drugs Sales in Volume by Region (2027-2032)
- 4.3.2 Global Cystic Fibrosis Drugs Sales in Value by Region (2027-2032)
- 4.3.3 Global Cystic Fibrosis Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cystic Fibrosis Drugs by Application
- 5.1 Cystic Fibrosis Drugs Market by Application
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Other
- 5.2 Global Cystic Fibrosis Drugs Market Size by Application
- 5.2.1 Global Cystic Fibrosis Drugs Market Size Overview by Application (2021-2032)
- 5.2.2 Global Cystic Fibrosis Drugs Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Cystic Fibrosis Drugs Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Cystic Fibrosis Drugs Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Cystic Fibrosis Drugs Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Cystic Fibrosis Drugs Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Cystic Fibrosis Drugs Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Cystic Fibrosis Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Abbott
- 6.1.1 Abbott Company Information
- 6.1.2 Abbott Business Overview
- 6.1.3 Abbott Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Abbott Cystic Fibrosis Drugs Product Portfolio
- 6.1.5 Abbott Recent Developments
- 6.2 Johnson & Johnson
- 6.2.1 Johnson & Johnson Company Information
- 6.2.2 Johnson & Johnson Business Overview
- 6.2.3 Johnson & Johnson Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Johnson & Johnson Cystic Fibrosis Drugs Product Portfolio
- 6.2.5 Johnson & Johnson Recent Developments
- 6.3 Novartis
- 6.3.1 Novartis Company Information
- 6.3.2 Novartis Business Overview
- 6.3.3 Novartis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Novartis Cystic Fibrosis Drugs Product Portfolio
- 6.3.5 Novartis Recent Developments
- 6.4 Vertex Pharmaceuticals
- 6.4.1 Vertex Pharmaceuticals Company Information
- 6.4.2 Vertex Pharmaceuticals Business Overview
- 6.4.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
- 6.4.5 Vertex Pharmaceuticals Recent Developments
- 6.5 Venus Remedies
- 6.5.1 Venus Remedies Company Information
- 6.5.2 Venus Remedies Business Overview
- 6.5.3 Venus Remedies Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Venus Remedies Cystic Fibrosis Drugs Product Portfolio
- 6.5.5 Venus Remedies Recent Developments
- 6.6 United Medical
- 6.6.1 United Medical Company Information
- 6.6.2 United Medical Business Overview
- 6.6.3 United Medical Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 United Medical Cystic Fibrosis Drugs Product Portfolio
- 6.6.5 United Medical Recent Developments
- 6.7 PTC Therapeutics
- 6.7.1 PTC Therapeutics Company Information
- 6.7.2 PTC Therapeutics Business Overview
- 6.7.3 PTC Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 PTC Therapeutics Cystic Fibrosis Drugs Product Portfolio
- 6.7.5 PTC Therapeutics Recent Developments
- 6.8 Proteostasis Therapeutics
- 6.8.1 Proteostasis Therapeutics Company Information
- 6.8.2 Proteostasis Therapeutics Business Overview
- 6.8.3 Proteostasis Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Proteostasis Therapeutics Cystic Fibrosis Drugs Product Portfolio
- 6.8.5 Proteostasis Therapeutics Recent Developments
- 6.9 Pharmaxis
- 6.9.1 Pharmaxis Company Information
- 6.9.2 Pharmaxis Business Overview
- 6.9.3 Pharmaxis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Pharmaxis Cystic Fibrosis Drugs Product Portfolio
- 6.9.5 Pharmaxis Recent Developments
- 6.10 PharmaSwiss
- 6.10.1 PharmaSwiss Company Information
- 6.10.2 PharmaSwiss Business Overview
- 6.10.3 PharmaSwiss Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 PharmaSwiss Cystic Fibrosis Drugs Product Portfolio
- 6.10.5 PharmaSwiss Recent Developments
- 6.11 Novo Nordisk
- 6.11.1 Novo Nordisk Company Information
- 6.11.2 Novo Nordisk Business Overview
- 6.11.3 Novo Nordisk Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Novo Nordisk Cystic Fibrosis Drugs Product Portfolio
- 6.11.5 Novo Nordisk Recent Developments
- 6.12 Neovii Biotech
- 6.12.1 Neovii Biotech Company Information
- 6.12.2 Neovii Biotech Business Overview
- 6.12.3 Neovii Biotech Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Neovii Biotech Cystic Fibrosis Drugs Product Portfolio
- 6.12.5 Neovii Biotech Recent Developments
- 6.13 Merck Sharp & Dohme
- 6.13.1 Merck Sharp & Dohme Company Information
- 6.13.2 Merck Sharp & Dohme Business Overview
- 6.13.3 Merck Sharp & Dohme Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Merck Sharp & Dohme Cystic Fibrosis Drugs Product Portfolio
- 6.13.5 Merck Sharp & Dohme Recent Developments
- 6.14 Insmed
- 6.14.1 Insmed Company Information
- 6.14.2 Insmed Business Overview
- 6.14.3 Insmed Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Insmed Cystic Fibrosis Drugs Product Portfolio
- 6.14.5 Insmed Recent Developments
- 6.15 Gilead Sciences
- 6.15.1 Gilead Sciences Company Information
- 6.15.2 Gilead Sciences Business Overview
- 6.15.3 Gilead Sciences Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Gilead Sciences Cystic Fibrosis Drugs Product Portfolio
- 6.15.5 Gilead Sciences Recent Developments
- 6.16 Genzyme
- 6.16.1 Genzyme Company Information
- 6.16.2 Genzyme Business Overview
- 6.16.3 Genzyme Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Genzyme Cystic Fibrosis Drugs Product Portfolio
- 6.16.5 Genzyme Recent Developments
- 6.17 F. Hoffmann-La Roche
- 6.17.1 F. Hoffmann-La Roche Company Information
- 6.17.2 F. Hoffmann-La Roche Business Overview
- 6.17.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Portfolio
- 6.17.5 F. Hoffmann-La Roche Recent Developments
- 6.18 Corbus Pharmaceuticals
- 6.18.1 Corbus Pharmaceuticals Company Information
- 6.18.2 Corbus Pharmaceuticals Business Overview
- 6.18.3 Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
- 6.18.5 Corbus Pharmaceuticals Recent Developments
- 6.19 Chiesi Farmaceutici
- 6.19.1 Chiesi Farmaceutici Company Information
- 6.19.2 Chiesi Farmaceutici Business Overview
- 6.19.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.19.4 Chiesi Farmaceutici Cystic Fibrosis Drugs Product Portfolio
- 6.19.5 Chiesi Farmaceutici Recent Developments
- 6.20 Boehringer Ingelheim
- 6.20.1 Boehringer Ingelheim Company Information
- 6.20.2 Boehringer Ingelheim Business Overview
- 6.20.3 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.20.4 Boehringer Ingelheim Cystic Fibrosis Drugs Product Portfolio
- 6.20.5 Boehringer Ingelheim Recent Developments
- 6.21 Arcturus Therapeutics
- 6.21.1 Arcturus Therapeutics Company Information
- 6.21.2 Arcturus Therapeutics Business Overview
- 6.21.3 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.21.4 Arcturus Therapeutics Cystic Fibrosis Drugs Product Portfolio
- 6.21.5 Arcturus Therapeutics Recent Developments
- 6.22 Anthera Pharmaceuticals
- 6.22.1 Anthera Pharmaceuticals Company Information
- 6.22.2 Anthera Pharmaceuticals Business Overview
- 6.22.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.22.4 Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Portfolio
- 6.22.5 Anthera Pharmaceuticals Recent Developments
- 6.23 Actavis
- 6.23.1 Actavis Company Information
- 6.23.2 Actavis Business Overview
- 6.23.3 Actavis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.23.4 Actavis Cystic Fibrosis Drugs Product Portfolio
- 6.23.5 Actavis Recent Developments
7 North America by Country
- 7.1 North America Cystic Fibrosis Drugs Sales by Country
- 7.1.1 North America Cystic Fibrosis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Cystic Fibrosis Drugs Sales by Country (2021-2026)
- 7.1.3 North America Cystic Fibrosis Drugs Sales Forecast by Country (2027-2032)
- 7.2 North America Cystic Fibrosis Drugs Market Size by Country
- 7.2.1 North America Cystic Fibrosis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Cystic Fibrosis Drugs Market Size by Country (2021-2026)
- 7.2.3 North America Cystic Fibrosis Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Cystic Fibrosis Drugs Sales by Country
- 8.1.1 Europe Cystic Fibrosis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Cystic Fibrosis Drugs Sales by Country (2021-2026)
- 8.1.3 Europe Cystic Fibrosis Drugs Sales Forecast by Country (2027-2032)
- 8.2 Europe Cystic Fibrosis Drugs Market Size by Country
- 8.2.1 Europe Cystic Fibrosis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Cystic Fibrosis Drugs Market Size by Country (2021-2026)
- 8.2.3 Europe Cystic Fibrosis Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Cystic Fibrosis Drugs Sales by Country
- 9.1.1 Asia-Pacific Cystic Fibrosis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Cystic Fibrosis Drugs Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Cystic Fibrosis Drugs Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Cystic Fibrosis Drugs Market Size by Country
- 9.2.1 Asia-Pacific Cystic Fibrosis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Cystic Fibrosis Drugs Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Cystic Fibrosis Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Cystic Fibrosis Drugs Sales by Country
- 10.1.1 South America Cystic Fibrosis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Cystic Fibrosis Drugs Sales by Country (2021-2026)
- 10.1.3 South America Cystic Fibrosis Drugs Sales Forecast by Country (2027-2032)
- 10.2 South America Cystic Fibrosis Drugs Market Size by Country
- 10.2.1 South America Cystic Fibrosis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Cystic Fibrosis Drugs Market Size by Country (2021-2026)
- 10.2.3 South America Cystic Fibrosis Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Cystic Fibrosis Drugs Sales by Country
- 11.1.1 Middle East and Africa Cystic Fibrosis Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Cystic Fibrosis Drugs Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Cystic Fibrosis Drugs Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Cystic Fibrosis Drugs Market Size by Country
- 11.2.1 Middle East and Africa Cystic Fibrosis Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Cystic Fibrosis Drugs Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Cystic Fibrosis Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Cystic Fibrosis Drugs Value Chain Analysis
- 12.1.1 Cystic Fibrosis Drugs Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Cystic Fibrosis Drugs Production Mode & Process
- 12.2 Cystic Fibrosis Drugs Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Cystic Fibrosis Drugs Distributors
- 12.2.3 Cystic Fibrosis Drugs Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,450USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst